Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Jason Bertola
Advertisement
Jason Bertolaexecutive director is of Commercial Development for the Advanced Synthesis Platform at Lonza in North America
Articles by Jason Bertola
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Winners of the 2026 CPHI Pharma Awards Announced
2
Thermo Fisher Scientific Exhibits New Solutions and Expanded Capabilities at CPHI Milan
3
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
4
Can Continuous Tableting End Scale-Up for Complex Oral Drugs?
5